QUOTE AND NEWS
FiercePharma  Jul 17  Comment 
It’s been more than a year since analysts first said Valeant could sell off its Obagi Medical Products business in a cash-raising effort, but the Canadian drugmaker has finally found a taker.
MarketWatch  Jul 17  Comment 
Valeant Pharmaceuticals International Inc. said Monday it has reached an agreement to sell its Obagi Medical Products business to Haitong International Zhonghua Finance Acquisition Fund I LP for $190 million in cash. Obagi is a specialty drug...
Reuters  May 17  Comment 
* Valeant Pharmaceuticals considering disposal Of Obagi Medical Products Inc, dermatology company it acquired in 2013, as well as Provenge - Bloomberg
The Hindu Business Line  Sep 8  Comment 
Bausch + Lomb India on Tuesday said that it is entering in premium professional skincare segment, with the launch of Obagi’s range. The products will be available through India’s leading...
Cloud Computing  Mar 18  Comment 
ZTE Corporation (« ZTE ») (code titre action H : 0763.HK / code titre action A : 000063.SZ), fournisseur mondial coté en Bourse d'équipements de télécommunications, de solutions réseau et d'appareils mobiles, reste dans...
DailyFinance  Jan 29  Comment 
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/29/14 -- Sirona Biochem Corp. (TSX VENTURE:SBM)(OTCQX:SRBCF)(FRANKFURT:ZSB) announced today the formal execution of the global exclusive licensing agreement with Obagi Medical Products...
Benzinga  Apr 25  Comment 
Valeant Pharmaceuticals International (NYSE: VRX) today announced the expiration of the tender offer (the "Offer") by a subsidiary of Valeant Pharmaceuticals International ("VPI") to purchase all of the outstanding shares of Obagi Medical...
The Globe and Mail  Apr 25  Comment 
Montreal-based company bid $24 per share for medical products firm





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki